[go: up one dir, main page]

Chislov et al., 2017 - Google Patents

Complex formation of cyclodextrins with some pharmacologically active 1, 2, 4-thiadiazole derivatives: Thermodynamics and binding mode

Chislov et al., 2017

View PDF
Document ID
9606866931148828043
Author
Chislov M
Silyukov O
Kumeev R
Proshin A
Perlovich G
Terekhova I
Publication year
Publication venue
Journal of Thermal Analysis and Calorimetry

External Links

Snippet

Abstract Previously synthesized 1, 2, 4-thiadiazole derivatives displayed an activity in the treatment of Alzheimer's disease; however, these compounds are poorly soluble in aqueous solutions. Inclusion complex formation with cyclodextrins is proposed for the development of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
    • A61K47/48969—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene inclusion being performed with a cyclodextrin

Similar Documents

Publication Publication Date Title
Medronho et al. Inclusion complexes of rosmarinic acid and cyclodextrins: stoichiometry, association constants, and antioxidant potential
Suvarna et al. Inclusion complexes of nateglinide with HP–β–CD and L-arginine for solubility and dissolution enhancement: preparation, characterization, and molecular docking study
Tang et al. Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β-and 2, 6-di-O-methyl-β-cyclodextrin
Wang et al. The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin
Yan et al. Experimental and computational studies of naringin/cyclodextrin inclusion complexation
Racz et al. Inclusion of α-lipoic acid in β-cyclodextrin. Physical–chemical and structural characterization
Maeda et al. Inclusion complexes of melatonin with modified cyclodextrins
Yang et al. Preparation and release behaviour of the inclusion complexes of phenylethanol with β‐cyclodextrin
López-Méndez et al. Convergent click synthesis of macromolecular dendritic β-cyclodextrin derivatives as non-conventional drug carriers: Albendazole as guest model
Pirnau et al. The complexation of flurbiprofen with β-cyclodextrin: a NMR study in aqueous solution
Tačić et al. Inclusion complexes of sulfanilamide with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin
Roy et al. Study to synthesize and characterize host-guest encapsulation of antidiabetic drug (TgC) and hydroxy propyl-β-cyclodextrin augmenting the antidiabetic applicability in biological system
Tănase et al. Physicochemical characterization and molecular modeling study of host–guest systems of aripiprazole and functionalized cyclodextrins
Fateminasab et al. Detailed chemical characterization and molecular modeling of serotonin inclusion complex with unmodified β-cyclodextrin
Aramă et al. Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-β-cyclodextrin (Captisol®)
Upadhyay et al. Molecular recognition of flunarizine dihydrochloride and β-cyclodextrin inclusion complex by NMR and computational approaches
Leonis et al. Antihypertensive activity and molecular interactions of irbesartan in complex with 2‐hydroxypropyl‐β‐cyclodextrin
Brusnikina et al. Effect of cyclodextrin complexation on solubility of novel anti-Alzheimer 1, 2, 4-thiadiazole derivative
Chislov et al. Complex formation of cyclodextrins with some pharmacologically active 1, 2, 4-thiadiazole derivatives: Thermodynamics and binding mode
Azzali et al. Tuning the solubility of the herbicide bentazon: from salt to neutral and to inclusion complexes
Usacheva et al. Host–guest inclusion complex of β-cyclodextrin and benzoic acid in water–ethanol solvents: Spectroscopic and thermodynamic characterization of complex formation
Rajamohan et al. Significantly improving the solubility and anti-inflammatory activity of fenofibric acid with native and methyl-substituted beta-cyclodextrins via complexation
Cowins et al. Preparation and characterization of β-sitosterol/β-cyclodextrin crystalline inclusion complexes
Siva et al. Encompassment of phthalyl sulfacetamide in α-and β-cyclodextrin using ultrasonication: Physicochemical and computational modeling investigations
Sbârcea et al. Fosinopril sodium–Hydroxypropyl-β-cyclodextrin inclusion complex: thermal decomposition kinetics and compatibility studies